Cryptogenic stroke, aortic arch atheroma, patent foramen ovale, and the risk of stroke

Cerebrovascular Diseases

Volumn 20, Issue SUPPL. 2, 2005, Pages 68-74

  Amarenco, Pierre ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Aortic arch atheroma; Cryptogenic stroke; Patent foramen ovale; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ACUTE CORONARY SYNDROME; AORTA ARCH ATHEROMA; AORTA THROMBOSIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BLEEDING; BRAIN INFARCTION; CONFERENCE PAPER; CRYPTOGENIC STROKE; HEART ATRIUM SEPTUM DEFECT; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBUS; ADULT; AGE; AGED; AORTA ARCH SYNDROME; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; HEART SEPTUM DEFECT; PATHOLOGY; RECURRENT DISEASE; REVIEW; RISK;

ADULT; AGE FACTORS; AGED; ANTICOAGULANTS; AORTIC ARCH SYNDROMES; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; RECURRENCE; RISK;

EID: 33644799501     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089358     Document Type: Conference Paper

References (35)

1. Amarenco P, Duyckaerts C, Tzourio C, Hénin D, Bousser M-G, Hauw J-J: The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;326:221-225.
2. Khathibzadeh M, Mitusch R, Stierle U, Gromoll B, Sheikhzadeh: Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 1996;27:664-669.
3. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, Chauvel C, Touboul P-J, Bousser M-G: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331:1474-1479.
4. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA: Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke 1995;26:218-224.
5. Tunick PA, Perez JL, Kronzon I: Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991;115:423-427.
6. Nihoyannopoulos P, Joshi J, Athanasopoulos G, Oakley CM: Detection of atherosclerotic lesions in the aorta by transesophageal echography. Am J Cardiol 1993;71:1208-1212.
7. Stone DA, Hawke MW, LaMonte M, Kittner SJ, Acosta J, Corretti M, Sample C, Price TR, Plotnick GD: Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J 1995;130:105-108.
8. Di Tullio MR, Sacco RL, Gersony D, Nayak H, Weslow RG, Kargman DE, Homma S: Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996;46:1560-1566.
9. Dávila-Román VG, Barzilai B, Wareing TH, Murphy SF, Schechtman KB, Kouchoukos NT: Atherosclerosis of the ascending aorta. Prevalence and role as independent predictor of cerebrovascular events in cardiac patients. Stroke 1994;25:2010-2016.
10. The French Study of Aortic Plaques in Stroke Group: Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996;334:1216-1221.
11. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I: High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol 1994;23:1085-1090.
12. Mitusch R, Doherty C, Wucherpfennig H, Memmesheimer, Tepe C, Stierle U, Kessler C, Sheikhzadeh A: Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997;28:36-39.
13. Dávila-Román V, Murphy SF, Nickerson NJ, Kouchoukos N, Schechtman K, Barzilai B: Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. J Am Coll Cardiol 1999;33:1308-1316.
14. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser M-G, Amarenco P; on behalf of the FAPS investigators: Aortic plaque morphology and vascular events. A follow-up study in patients with ischemic stroke. Circulation 1997;96:3838-3841.
15. Tunick PA, Nayar AC, Goodkin GM, Mirchandani S, Francescone S, Rosenzweig BP, Freedberg RS, Katz ES, Applebaum RM, Kronzon I; for the NYU Atheroma Group: Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol 2002;90:1320-1325.
16. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997;42:857-865.
17. Mohr JP, Thompson JLP, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP, Jackson CM, Pullicino P; for the Warfarin-Aspirin Recurrent Stroke Study Group: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-1451.
18. Petty GW, et al: Frequency of major complications of aspirin, warfarin etc. Ann Intern Med 1999;130:14-22.
19. CAPRIE Steering Committee: A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
20. Harker LA, et al: Clopidogrel inhibition of stent, graft, and vascular thrombogenesis. Circulation 1998;98:2461-2469.
21. Steinhubl SR, Berger PB, Mann JT, Fry ETA, DeLago A, Wilmer C, Topol EJ; for the CREDO Investigators: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial. JAMA 2002;288:2411-2420.
22. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
23. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; on behalf of the MATCH investigators: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.
24. Amarenco P, Donnan GA: Should the MATCH results be extrapolated to all stroke patients and affect on-going trials evaluating clopidogrel plus aspirin? Stroke 2004;35:2606-2608.
25. Lechat P, Mas JL, Lascaut G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y: Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
26. Overell JR, Bone I, Lees KR: Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
27. Cabanes L, Mas J-L, Cohen A, Amarenco P, Cabanes PA, Oubari P, Chedru F, Guérin F, Bousser M-G, de Recondo J: Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865-1873.
28. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL: Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993;24:31-34.
29. Berthet K, Lavergne T, Cohen A, Guize L, Bousser M-G, Le Heuzey J-Y, Amarenco P: Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398-403.
30. Allessie MA, Rensma PL, Brugada J, Smeets JL, Penn O, Kirchhof CJ: Pathophysiology of atrial fibrillation; in Zipes DP, Jalife J (eds): Cardiac Electrophysiology. From Cell to Bedside. Philadelphia, WB Saunders, 1990, p 548.
31. Ravelli F, Allessie M: Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-Perfused rabbit heart. Circulation 1997;96:1686-1695.
32. Mas JL, Arquizan C, Lamy C, et al: Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
33. Homma S, Sacco RL, Di Tullio MR, Sciacca RR; for the PFO In Cryptogenic Stroke Study (PICSS) Investigators: Effect of medical treatment in stroke patients with patent foramen ovale. Patent Foramen Ovale In Stroke Study. Circulation 2002;105:2625-2631.
34. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P: Antithrombotic and thrombolytic therapy for ischemic stroke. CHEST 2004;126(suppl):S483-S512.
35. Amarenco P: Patent foramen ovale and stroke: smoking gun or guilty by association? Heart 2005;91:441-443.